(Q66392891)

English

RICE-ibrutinib in Relapsed DLBCL

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

A Phase II Study of Ibrutinib With R-ICE Chemotherapy for Transplant-eligible Relapsed/Refractory Diffuse Large B-cell Lymphoma Followed by Ibrutinib Maintenance in Patients Not Achieving a Complete Response at Pre-transplant Interim Assessment (English)
0 references
0 references
13 December 2016
0 references
August 2023
0 references
34
0 references
21 year
0 references
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit